Showing results (1201-1210 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|June 29, 2011
Oral mucositisStephen T Sonis
Anti-Cancer Drugs|July 20, 2011
Surgical removal of metastases after successful treatment containing bevacizumab in metastatic colorectal cancerSergio Afonso, Gustavo Viani, Vitor Afonso, et al.
Anti-Cancer Drugs|July 20, 2011
Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancerJosé Aurillo Rocha
Anti-Cancer Drugs|September 22, 2011
Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatmentFilip Yves De Vos, Willem Joost Lesterhuis, Roger Johannes Brüggemann, et al.
Anti-Cancer Drugs|September 22, 2011
Antimetastatic activity isolated from Colocasia esculenta (taro)Namita Kundu, Patricia Campbell, Brian Hampton, et al.
Anti-Cancer Drugs|August 23, 2011
Methyl-β-cyclodextrin induces programmed cell death in chronic myeloid leukemia cells and, combined with imatinib, produces a synergistic downregulation of ERK/SPK1 signalingJun Yan, Qing-Fang Li, Li-Sheng Wang, et al.
Anti-Cancer Drugs|June 7, 2011
Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: therapeutic effect of the Antp-conjugated Smac peptideXing-yuan Xiao, Guo-song Jiang, Liang Wang, et al.
Anti-Cancer Drugs|May 14, 2011
Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinomaMaria Angeles Vaz, Vanessa Pachón, Enrique Grande, et al.
Anti-Cancer Drugs|June 4, 2011
Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycinXiaodong Qi, Zhikun Chang, Jin Song, et al.
Anti-Cancer Drugs|June 14, 2011
Triphendiol (NV-196), development of a novel therapy for pancreatic cancerXiaohong Wang, Robert McKernan, Ki H Kim, et al.
Pageof 464